Oxidation of bilirubin by brain mitochondrial membranes - Dependence on cell type and postnatal age

Biochemical and Molecular Medicine

Volumn 60, Issue 2, 1997, Pages 155-160

  Hansen, Thor Willy Ruud ^a   Allen, Jeffrey W ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADOLESCENT; AGE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILIRUBIN METABOLISM; BRAIN MATURATION; BRAIN MITOCHONDRION; BRAIN NERVE CELL; BRAIN SYNAPTOSOME; CELL TYPE; CONTROLLED STUDY; GLIA CELL; MITOCHONDRIAL MEMBRANE; NEWBORN; NONHUMAN; OPTICAL DENSITY; OXIDATION; RAT;

ANIMALIA; GILA; ORYCTOLAGUS CUNICULUS;

EID: 0031127918     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.2565     Document Type: Article

References (39)

1. Hansen T WR, Bratlid D. Bilirubin and brain toxicity. Acta Paediatr Scand. 75:1986;513-522.
2. Hansen T WR, Mathiesen S BW, Walaas S I. Bilirubin has widespread inhibitory effects on protein phosphorylation. Pediatr Res. 39:1996;1072-1077.
3. Bowen W R, Porter E, Waters W J. The protective effect of albumin in bilirubin toxicity in newborn puppies. Am J Dis Child. 48:1959;568.
4. Lie S O, Bratlid D. The protective effect of albumin on bilirubin toxicity in human fibroblasts. Scand J Clin Invest. 26:1970;37-41.
5. Cowger M L. Mechanism of bilirubin toxicity on tissue culture cells: Factors that affect toxicity, reversibility by albumin, and comparison with other respiratory poisons and surfactants. Biochem Med. 5:1971;1-16.
6. Bratlid D, Rugstad H E. Effect of albumin binding on bilirubin conjugation and toxicity in cell culture of a clonal strain of rat hepatoma cells. Scand J Clin Lab Invest. 29:1972;461-466.
7. 14. J Clin Invest. 42:1963;1720-1734.
8. Brodersen R, Bartels P. Enzymatic oxidation of bilirubin. Eur J Biochem. 10:1969;468-473.
9. Knobloch E, Miler I. Interaction of bilirubin with human lymphocytes and granulocytes - The effect on bilirubin metabolism. Folia Microbiol. 31:1986;387-393.
10. Yokosuka O, Billing B. Enzymatic oxidation of bilirubin by intestinal mucosa. Biochim Biophys Acta. 923:1987;268-274.
11. Kapitulnik J, Ostrow J D. Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases. Proc Natl Acad Sci USA. 75:1977;682-685.
12. Cohen A N, Kapitulnik J, Ostrow J D, Webster C C. Effect of combined treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and phototherapy on bilirubin metabolism in the jaundiced Gunn rat. Hepatology. 6:1986;490-494.
13. de Matteis F, Dawson S, Boobis A R, Comoglio A. Inducible bilirubin-degrading system of rat liver microsomes: Role of cytochrome P450IA1. Mol Pharmacol. 40:1991;686-691.
14. Kapitulnik J, Gonzalez F J. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol. 43:1993;722-725.
15. Hansen T WR, Allen J. Bilirubin-oxidizing activity in rat brain. Biol Neonate. 70:1996;289-295.
16. Hansen T WR, Allen J W. Hemolytic anemia does not increase entry into, nor alter rate of clearance of bilirubin from rat brain. Biol Neonate. 69:1996;268-274.
17. Sawasaki Y, Yamada N, Nakajima H. Developmental features of cerebellar hypoplasia and brain bilirubin levels in a mutant (Gunn) rat with hereditary hyperbilirubinemia. J Neurochem. 27:1976;577-583.
18. Moore P J, Karp W B. Further observations on the effect of bilirubin encephalopathy on the Purkinje cell population in Gunn rats. Exp Neurol. 69:1980;408-413.
19. Aono S, Sato H, Semba R, Kashiwamata S. Two proteins associated with cerebellar hypoplasia in jaundiced Gunn rats. Neurochem Res. 8:1983;743-756.
20. O'Callaghan J P, Miller D B. Cerebellar hypoplasia in the Gunn rat is associated with changes in neurotypic and gliotypic proteins. J Pharmacol Exp Ther. 234:1985;522-533.
21. Aoki E, Semba R, Keino H, Katoh-Semba R, Kashiwamata S. Postnatal development of gamma-aminobutyric acid (GABA) neurons in the cerebellum of jaundiced Gunn rats: A study with anti-GABA antiserum. Biomed Res. 6:1985;145-152.
22. Notter M FD, Kendig J W. Differential sensitivity of neural cells to bilirubin toxicity. Exp Neurol. 94:1986;670-682.
23. Whittaker V P, Barker L A. The subcellular fractionation of brain tissue with special reference to the preparation of synaptosomes and their component organelles. Methods of Neurochemistry. 1972;Dekker, New York. p. 1-52.
24. Jacobsen J, Wennberg R P. Determination of unbound bilirubin in the serum of newborns. Clin Chem. 20:1974;783-789.
25. Brodersen R, Stern L. Deposition of bilirubin acid in the central nervous system - A hypothesis for the development of kernicterus. Acta Paediatr Scand. 79:1990;12-19.
26. 3. Biol Neonate. 63:1993;35-39.
27. Walther B, Ghersi-Egea J F, Minn A, Siest G. Subcellular distribution of cytochrome P-450 in the brain. Brain Res. 375:1986;338-344.
28. Leong S F, Lai J CK, Lim L, Clark J B. The activities of some energy-metabolizing enzymes in nonsynaptic (free) and synaptic mitochondria derived from selected brain regions. J Neurochem. 42:1984;1306-1312.
29. ++335. Pediatr Res. 25:1989;364-368.
30. Schutta H S, Johnson L. Electron microscopic observations on acute bilirubin encephalopathy in Gunn rats induced by sulfadimethoxine. Lab Invest. 24:1971;82-89.
31. Jew J Y, Williams T H. Ultrastructural aspects of bilirubin encephalopathy in cochlear nuclei of the Gunn rat. J Anat. 124:1977;599-614.
32. Wong-Riley M. Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci. 12:1989;94-101.
33. Maisels M J. Jaundice. Avery G B, Fletcher M A, MacDonald M G. Neonatology, Pathophysiology and Management of the Newborn. 1994;630-725 Lippincott, Philadelphia.
34. 125. Pediatr Res. 25:1989;452-456.
35. Roger C, Koziel V, Vert P, Nehlig A. Autoradiographic mapping of local cerebral permeability to bilirubin in immature rats: Effects of hyperbilirubinemia. Pediatr Res. 39:1995;64-71.
36. Malik P, McKenna M C, Tildon J T. Regulation of the malate dehydrogenases from neonatal, adolescent, and mature rat brain. Neurochem Res. 18:1991;247-257.
37. George J, Farrell G C. Role of human hepatic cytochromes P450 in drug metabolism and toxicity. Aust NZ J Med. 21:1991;356-362.
38. Gonzalez F J, Idle J R. Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin Pharmacokinet. 26:1994;59-70.
39. Halpert J R, Gunegerich F P, Bend J R, Correia M A. Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol. 125:1994;163-175.